HALNEURON® (Tetrodotoxin for Injection) clinical trials

Evaluation of quantitative sensory testing (QST) using subcutaneous administration of single escalating doses of halneuron® (tetrodotoxin (TTX)) for injection in healthy volunteers

This study is testing a new medicine, HALNEURON, which contains tetrodotoxin (TTX), in healthy volunteers. It will look at how different doses affect how people feel sensations like touch or temperature, to see if it could help with pain in the future.